Termen, Switzerland

Lukas Utiger

This inventor holds 1 USPTO granted patent. Top assignee: Lonza Ag. Active years: 1998.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Lukas Utiger

Introduction

Lukas Utiger is a notable inventor based in Termen, Switzerland. He has made significant contributions to the field of chemistry, particularly in the preparation of nicotinamide. His innovative approach has led to the development of a unique process that enhances the efficiency of this important compound.

Latest Patents

Lukas holds a patent for a process for preparing nicotinamide. This process involves several stages, starting with the catalytic conversion of 2-methyl-1,5-diaminopentane into 3-picoline. Following this, 3-picoline is transformed into 3-cyanopyridine through ammonoxidation. Finally, the 3-cyanopyridine undergoes microbiological conversion to yield nicotinamide. This patent showcases his expertise and innovative thinking in chemical processes.

Career Highlights

Lukas is currently employed at Lonza AG, a leading global company in the life sciences sector. His work at Lonza AG has allowed him to apply his inventive skills in a practical setting, contributing to advancements in pharmaceutical and chemical manufacturing.

Collaborations

Lukas collaborates with talented professionals in his field, including Markus Rohner and Roderick J Chuck. These collaborations enhance his research and development efforts, fostering innovation and creativity in his projects.

Conclusion

Lukas Utiger's contributions to the field of chemistry, particularly through his patent for the preparation of nicotinamide, highlight his innovative spirit and dedication to advancing scientific knowledge. His work at Lonza AG and collaborations with esteemed colleagues further underscore his impact in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…